Ivana Magnani
Overview
Explore the profile of Ivana Magnani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
261
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roversi G, Colombo E, Magnani I, Gervasini C, Maggiore G, Paradisi M, et al.
Genet Mol Biol
. 2021 Aug;
44(3):e20200332.
PMID: 34358284
Two Italian patients with the initial clinical diagnosis of Rothmund-Thomson syndrome were negative for RECQL4 mutations but showed in peripheral blood cells a spontaneous chromosomal instability significantly higher than controls....
2.
Rovina D, Fontana L, Monti L, Novielli C, Panini N, Sirchia S, et al.
Eur J Cell Biol
. 2014 Aug;
93(8-9):355-65.
PMID: 25123532
MARK4 is a serine-threonine kinase that phosphorylates MAP proteins, increasing microtubule dynamics. MARK4 differs from the other members of the MARK family for encoding two isoforms (MARK4L and MARK4S), differentially...
3.
Magnani I, Novielli C, Fontana L, Tabano S, Rovina D, Moroni R, et al.
Anal Cell Pathol (Amst)
. 2011 Dec;
34(6):319-38.
PMID: 22156016
Background: MAP/microtubule affinity-regulating kinase 4 (MARK4) is a serine-threonine kinase expressed in two spliced isoforms, MARK4L and MARK4S, of which MARK4L is a candidate for a role in neoplastic transformation....
4.
Pedranzini L, Mottadelli F, Ronzoni S, Rossella F, Ferracin M, Magnani I, et al.
Leuk Res
. 2010 Mar;
34(10):1287-95.
PMID: 20227111
The t(8;21) Acute Myeloid Leukaemia (AML) Kasumi-1 cell line with N822K KIT mutation, is a model system for leukemogenesis. As AML initiating cells reside in the CD34(+)CD38(-) fraction, we addressed...
5.
Magnani I, Novielli C, Bellini M, Roversi G, Bello L, Larizza L
Cell Oncol
. 2009 Sep;
31(5):357-70.
PMID: 19759416
Background: We have previously shown that the sustained expression of MARK4L transcripts in glioma and neural progenitors (NHNPs) declines after exposure to antisense MARK4L oligonucleotides in glioblastoma cell lines. Array-CGH...
6.
Gagliano N, Moscheni C, Torri C, Donetti E, Magnani I, Costa F, et al.
Anticancer Drugs
. 2007 Sep;
18(6):669-76.
PMID: 17762395
Glioblastoma is a highly malignant tumor, characterized by an unfavorable prognosis even in response to multidisciplinary treatment strategies, owing to its high-invasive phenotype. Ukrain, a semisynthetic thiophosphoric acid derivative of...
7.
Cassoni P, Senetta R, Castellano I, Ortolan E, Bosco M, Magnani I, et al.
Am J Surg Pathol
. 2007 Apr;
31(5):760-9.
PMID: 17460461
Caveolins are basic constituents of flask-shaped cell membrane microdomains (caveolae), which are involved in many cell functions, including signalling, trafficking, and cellular growth control. The distribution of caveolae within the...
8.
Gagliano N, Moscheni C, Torri C, Magnani I, Bertelli A, Nowicky W, et al.
Anticancer Drugs
. 2006 Jan;
17(2):189-94.
PMID: 16428937
Glioblastoma is a highly malignant brain tumor with a highly invasive phenotype and hence an unfavorable prognosis even in response to multidisciplinary treatment strategies. Ukrain, a semi-synthetic thiophosphoric acid derivative...
9.
Larizza L, Magnani I, Roversi G
Cancer Lett
. 2005 Nov;
232(1):107-20.
PMID: 16271439
Rothmund-Thomson Syndrome (RTS) is a rare autosomal recessive genodermatosis with a heterogeneous clinical profile. Mutations in RECQL4, encoding a RecQ DNA helicase, are present in a large fraction, but not...
10.
Magnani I, Moroni R, Ramona R, Roversi G, Beghini A, Pfundt R, et al.
Cancer Genet Cytogenet
. 2005 Aug;
161(2):140-5.
PMID: 16102584
Glioblastomas, the most frequent and malignant glial tumors, are known to be phenotypically heterogeneous. A low fraction of glioblastomas is associated with specific chromosomal losses at 1p and 19q, which...